Back to search results

EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease

Abroad (travel likely)RecruitingPHASE4

Conditions

Heart Failure With Preserved Ejection Fraction · End Stage Renal Disease on Dialysis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan

    Contact: Study coordinator (Chih-Cheng Wu, PhD) · chihchengwumd@gmail.com · 03 532 6151
    Contact: Principal Investigator (Chih-Cheng Wu, PhD)

  • Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan

    Contact: Study coordinator (Donna SH Lin, MD) · donna.lin24@gmail.com · 0912902379
    Contact: Principal Investigator (Donna SH Lin, MD)
Study leads

  • Donna SH Lin, MD

    Principal Investigator

    Shin Kong Wu Ho-Su Memorial Hospital

  • Chih-Cheng Wu, MD. PhD

    Principal Investigator

    National Taiwan University Hsin-Chu Hospital

View source on ClinicalTrials.gov(opens in a new tab)